Münz Christian
Viral Immunobiology, Institute of Experimental Immunology, University Hospital of Zürich, CH-8057 Zürich, Switzerland.
Annu Rev Immunol. 2009;27:423-49. doi: 10.1146/annurev.immunol.021908.132537.
Next to the proteasome, autophagy is the main catabolic pathway for the degradation of cytoplasmic constituents. The immune system uses it both as an effector mechanism to clear intracellular pathogens and as a mechanism to monitor its products for evidence of pathogen invasion and cellular transformation. Because autophagy delivers intracellular material for lysosomal degradation, its products are primarily loaded onto MHC class II molecules and are able to stimulate CD4+ T cells. This process might shape the self-tolerance of the CD4+ T cell repertoire and stimulate CD4+ T cell responses against pathogens and tumors. Beyond antigen processing, autophagy's role in cell survival is to assist the clonal expansion of B and T cells for efficient adaptive immune responses. These immune-enhancing functions make autophagy an attractive target for therapeutic manipulation in human disease.
除蛋白酶体之外,自噬是细胞质成分降解的主要分解代谢途径。免疫系统将其用作清除细胞内病原体的效应机制,以及监测其产物以获取病原体入侵和细胞转化证据的机制。由于自噬将细胞内物质输送至溶酶体进行降解,其产物主要加载到MHC II类分子上,并能够刺激CD4+ T细胞。这一过程可能塑造CD4+ T细胞库的自身耐受性,并刺激CD4+ T细胞针对病原体和肿瘤的反应。除了抗原加工外,自噬在细胞存活中的作用是协助B细胞和T细胞的克隆扩增,以实现高效的适应性免疫反应。这些免疫增强功能使自噬成为人类疾病治疗操作的一个有吸引力的靶点。